Mini–Hyper-CVD Plus Venetoclax for Relapsed/Refractory Acute Lymphoblastic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 1/2 Study of Mini-Hyper-CVD plus Venetoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Blood Adv 2024 Jan 11;[EPub Ahead of Print], NJ Short, EJ Jabbour, N Jain, J Senapati, LF Nasr, FG Haddad, Z Li, YC Hsiao, JJ Yang, N Pemmaraju, M Ohanian, WG Wierda, G Montalban-Bravo, G Borthakur, L Han, L Xiao, X Huang, R Abramova, M Zhao, R Garris, M Konopleva, F Ravandi, HM KantarjianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.